| scholarly article | Q13442814 |
| P50 | author | Deborah Zimmerman | Q91994896 |
| P2093 | author name string | Daniel Samaha | |
| Trisha Kandiah | |||
| P2860 | cites work | The 5-D itch scale: a new measure of pruritus. | Q33871967 |
| Setting research priorities for patients on or nearing dialysis | Q34292845 | ||
| Randomized, double-blind study with glycerol and paraffin in uremic xerosis. | Q34751820 | ||
| Comparison of Gabapentin and Ketotifen in Treatment of Uremic Pruritus in Hemodialysis Patients. | Q36697791 | ||
| Assessment of restless legs syndrome--methodological approaches for use in practice and clinical trials | Q36834254 | ||
| The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care | Q36887224 | ||
| Gabapentin: A promising therapy for uremic pruritus in hemodialysis patients: A randomized-controlled trial and review of literature | Q38797645 | ||
| Itchy skin--a clinical problem for haemodialysis patients | Q39331404 | ||
| A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients | Q43657244 | ||
| Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study | Q44030301 | ||
| Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial | Q45170301 | ||
| A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients | Q46343813 | ||
| Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study | Q46832897 | ||
| International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis | Q47688794 | ||
| Comparison of pregabalin with doxepin in the management of uremic pruritus: a randomized single blind clinical trial | Q47701692 | ||
| Cannabis for restless legs syndrome: a report of six patients | Q47715691 | ||
| Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation | Q47834285 | ||
| Comparison of pregabalin with ondansetron in treatment of uraemic pruritus in dialysis patients: a prospective, randomized, double-blind study | Q48069006 | ||
| L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. | Q53637701 | ||
| A Comparison of Symptom Prevalence in Far Advanced Cancer, AIDS, Heart Disease, Chronic Obstructive Pulmonary Disease and Renal Disease | Q57495640 | ||
| Comparative pilot study of symptoms and quality of life in cancer patients and patients with end stage renal disease | Q79294014 | ||
| Gabapentin: a promising drug for the treatment of uremic pruritus | Q80750289 | ||
| Symptom burden and quality of life in end-stage renal disease: a study of 179 patients on dialysis and palliative care | Q83202609 | ||
| The role of cannabinoids in dermatology | Q87849481 | ||
| European S2k Guideline on Chronic Pruritus | Q92735624 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | restless legs syndrome | Q916280 |
| P304 | page(s) | 2054358120954944 | |
| P577 | publication date | 2020-09-10 | |
| P1433 | published in | Canadian journal of kidney health and disease | Q27726098 |
| P1476 | title | Cannabis Use for Restless Legs Syndrome and Uremic Pruritus in in patients treated with maintenance dialysis: A Survey | |
| P478 | volume | 7 |
Search more.